...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >A comparison of in vitro and in vivo degradation of two CPC strain gauge coatings.
【24h】

A comparison of in vitro and in vivo degradation of two CPC strain gauge coatings.

机译:两种CPC应变片涂层在体外和体内降解的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Calcium phosphate ceramic (CPC) coated strain gauges have been used to measure bone strain in animal models for up to 16 weeks and are being developed to collect measurements in patients for periods of 1 year or more. A published surface roughening and heat treating procedure produced improved dry strength and in vivo stability of CPC-gauge interfaces after 16 weeks. The long term bond strength of two CPC-gauge interfaces prepared using the roughening and heat treating process were evaluated after up to 1 year in vitro and in vivo using a lap shear test. The feasibility of using an in vitro test to predict long term in vivo interface changes was established. A blended tricalcium phosphate + hydroxyapatite had a CPC-gauge interface strength which decreased from 6.07 +/- 2.64 MPa at 16 weeks to 4.71 +/- 1.840 MPa after 1 year in Hanks Balanced Salts (HBS). The same coating had a strength that decreased from 8.51 +/- 2.63 MPa at 16 weeks to 5.35 +/- 1 MPa after 1 year in vivo. A soluble calcium enhanced hydroxyapatite had an interface strength of 4.83 +/- 1.106 MPa after 16 weeks and 4.51+/- 1.100 MPa after 1 year in HBS. The same coating had an interface strength of 8.34 +/- 2.40 MPa after 16 weeks and 5.20 +/- 2.00 MPa after 1 year in vivo. Although interface strengths decreased slightly with time in vivo, after 1 year they were in the same strength range as published CPC-bone interface strengths of 4.8 +/- 2.4 MPa. Comparison of in vitro with in vivo results indicated that in vitro results were a good predictor of strength change in the blended CPC coating, but a poorer predictor of strength changes in the soluble calcium-enhanced coating. Copyright 2000 John Wiley & Sons, Inc.
机译:磷酸钙陶瓷(CPC)涂层应变仪已用于测量动物模型中的骨应变长达16周,并且正在开发以收集患者1年或更长时间的测量值。 16周后,已发布的表面粗糙化和热处理程序改善了CPC量规界面的干强度和体内稳定性。在经过长达1年的体内外实验后,使用搭接剪切试验评估了使用粗糙化和热处理工艺制备的两个CPC规界面的长期粘结强度。建立了使用体外测试预测长期体内界面变化的可行性。在Hanks Balanced Salts(HBS)中,混合的磷酸三钙+羟基磷灰石的CPC量规界面强度从16周的6.07 +/- 2.64 MPa降低到1年后的4.71 +/- 1.840 MPa。同一涂层的强度在体内一年后从16周的8.51 +/- 2.63 MPa降低到5.35 +/- 1 MPa。可溶性钙增强羟基磷灰石在HBS中的界面强度在16周后为4.83 +/- 1.106 MPa,在1年后为4.51 +/- 1.100 MPa。同一涂层在体内16周后的界面强度为8.34 +/- 2.40 MPa,在体内1年后的界面强度为5.20 +/- 2.00 MPa。尽管体内的界面强度随时间略有下降,但在一年后,它们的强度范围与公布的CPC骨界面强度4.8 +/- 2.4 MPa处于同一范围。体外结果与体内结果的比较表明,体外结果是共混CPC涂层强度变化的良好预测指标,而可溶性钙增强涂层强度变化的预测指标较差。版权所有2000 John Wiley&Sons,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号